ADVANCE System Testing: Benefit-risk Analysis of a Marketed Vaccine Using Multi-Criteria Decision Analysis and Individual-Level State Transition Modelling

Dec-20

Database General Analysis Virology and Immunisations

AUTHORS : Kaatje Bollaerts, P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan, 1 3001 Heverlee, Belgium (Vlierbeeklaan 18, 3010 Kessel-lo, Belgium) – Email: kaatje.bollaerts@p-95.com

JOURNAL : Vaccine

REFERENCE: 38(S2):B65-B75

DOI : 10.1016/j.vaccine.2019.09.034

Read more